期刊文献+

丁酸氯维地平4种杂质的合成 被引量:1

Synthesis of Four Impurities of Clevidipine Butyrate
下载PDF
导出
摘要 目的合成丁酸氯维地平的4个杂质。方法以2, 3-二氯苯甲醛、乙酰乙酸乙酯、双乙烯酮、3-羟基丙腈、丁酸氯甲酯为起始原料,经酯化、缩合、环合得到4-(2, 3-二氯苯基)-1, 4-二氢-2, 6-二甲基-3, 5-吡啶二羧酸乙酯氰乙基酯(A);A在丙酮中经氢氧化钠选择性水解得到4-(2, 3-二氯苯基)-1, 4-二氢-2, 6-二甲基-3, 5-吡啶二羧酸单乙酯(B);B在乙腈和碳酸钾的混合溶液中与丁酸氯甲酯发生酯化反应生成4-(2, 3-二氯苯基)-1, 4-二氢-2, 6-二甲基-3, 5-吡啶二羧酸乙酯丁酰氧基甲酯(C)。C氧化得到杂质4-(2, 3-二氯苯基)-2, 6-二甲基-3, 5-吡啶二羧酸乙酯丁酰氧基甲酯(D)。结果 4个目标物经质谱(MS),核磁共振氢谱(1H-NMR),核磁共振碳谱(13C-NMR)确证其化学结构。结论合成的4个杂质可作为丁酸氯维地平质量控制对照品。本工艺操作可行,原料易得。 Objective To synthesize four impurities of clevidipine butyrate. Methods Using 2, 3-dichlorobenzaldehyde, ethyl acetoacetate, diketene, 3-hydroxypropionitrile and chloromethyl butyrate as starting materials, 4-(2, 3-dichlorophenyl)-1, 4-dihydro-2, 6-dimethyl-3, 5-pyridyldicarboxylic acid ethyl cyanoethyl ester(A) was obtained by esterification, condensation and cyclization. A was selectively hydrolyzed by sodium hydroxide in acetone to obtain 4-(2, 3-dichlorophenyl)-1, 4-dihydro-2, 6-dimethyl-3, 5-pyridinedicarboxylic acid monoethyl ester(B). B was esterified with chloromethyl butyrate in a mixed solution of acetonitrile and potassium carbonate to produce 4-(2, 3-dichlorophenyl)-1, 4-dihydro-2, 6-dimethyl-3, 5-pyridinedicarboxylate butyryloxymethyl(C). C was oxidized to obtain an impurity 4-(2, 3-dichlorophenyl)-2, 6-dimethyl-3, 5-pyridinedicarboxylic acid ethyl butyryloxymethyl ester(D). Results The chemical structures of the four target chemicals were confirmed by MS, 1H-NMR and 13C-NMR. Conclusion The synthesized four impurities can be used as reference for quality control of clevidipine butyrate. The process is feasible and the raw materials are easily available.
作者 任业明 刘宜辉 邓玉晓 马新成 赵思太 段崇刚 REN Ye-ming;LIU Yi-hui;DENG Yu-xiao;MA Xin-cheng;ZHAO Si-tai;DUAN Chong-gang(Shandong Provincial Key Laboratory of Chemical Drugs,Shandong Academy of Pharmaceutical Sciences,Jinan 250101,China)
出处 《食品与药品》 CAS 2020年第4期276-279,共4页 Food and Drug
关键词 丁酸氯维地平 杂质 合成 高血压 clevidipine butyrate impurity synthesis hypertension
  • 相关文献

参考文献8

二级参考文献78

  • 1徐云根,华维一.尼莫地平的合成改进[J].中国医药工业杂志,2005,36(1):8-9. 被引量:6
  • 2王玉民,曹晓群,朱焰,张昌军,庞现红.特戊酸氯甲酯合成新工艺的研究[J].泰山医学院学报,2005,26(4):346-347. 被引量:2
  • 3辜正一,朱源.西尼地平的合成工艺改进[J].中国现代应用药学,2006,23(3):204-205. 被引量:4
  • 4US FDA, FDA approval letter [EB/OL]. [2008-08-10]. http://www.fda.gov/cder/foi/appletter/2008/022156s0001tr. pdf.
  • 5Varon J. Treatment of acute severe hypertension: current and newer agents [J]. Drugs, 2008, 68 (3) : 283-297.
  • 6Andersson KH, Nordlander M, Westerlund RC. Preparation of short-acting 2,6-dimethyl-4-phenyl-l,4-dihydropyridine- 3,5-dicarboxylate calcium antagonist antihypertensives: WO, 9512578 [P]. 1995-05-11. (CA 1995, 123: 313768).
  • 7Kosugi Y, Hori M, Nagasaka T. Synthesis of optically pure 1,4-dihydropyridine derivatives by means of diastereoisomeric separation of the hantzsch intermediates bearing (R)-l-phenylethylamino group [J]. Heterocycles, 1994, 39 (2): 591-602.
  • 8Mattson A, Svensson C, Thornblom K, et al. Manufacture of clevidipine from 4- (2,3-dichlorophenyl) -1,4-dihydro-5- methoxycarbonyl-2,6-dimethyl-3-pyridinecarboxylic acid: WO, 2000031035 [P]. 2000-06-02. (CA2000, 133: 6161).
  • 9Che D, Guntoori BR, Murthy KKS. Process to prepare 1,4-dihydropyridine intermediates and derivatives thereof: US, 20040204604 [P]. 2004-10-14.
  • 10Suh JJ, Hong YH. Synthesis of 1,4-dihydropyridine carboxylic acids (II) [J].Yakhak Hoechi, 1989, 33 (4) : 219-225.

共引文献27

同被引文献12

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部